Shares of Globeimmune, Inc. (OTCMKTS:GBIM – Get Free Report) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Globeimmune shares last traded at $0.00, with a volume of 0 shares.
Globeimmune Price Performance
Globeimmune Company Profile
GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.
Recommended Stories
- Five stocks we like better than Globeimmune
- Consumer Discretionary Stocks Explained
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Following Congress Stock Trades
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Stock Market Upgrades: What Are They?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Globeimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globeimmune and related companies with MarketBeat.com's FREE daily email newsletter.
